Global Chronic Idiopathic Constipation (CIC) Drugs Market, 2025: - Erie News Now | WICU & WSEE in Erie, PA

Global Chronic Idiopathic Constipation (CIC) Drugs Market, 2025: Emerging APAC Market & High Unmet Needs

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact

SOURCE Research and Markets

DUBLIN, October 3, 2017 /PRNewswire/ --

The "Global Chronic Idiopathic Constipation (CIC) Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 - 2025" report has been added to Research and Markets' offering.

Research and Markets Logo

The chronic idiopathic constipation drugs market was valued at USD 1889.85 Mn in 2017, and is expected to reach USD 2857.45 Mn by 2025, expanding at a CAGR of 6.4% from 2017 - 2025.

Growing awareness and increasing incidence and prevalence of chronic idiopathic constipation - CIC are the major factors driving the CIC drugs market worldwide. Growth in demand for CIC drugs in Asia Pacific, coupled with the huge gap of unmet needs in the region is expected to serve as a significant opportunity in the global market during forecast period.

In terms of market segmentation by drug type, Lubiprostone drugs segment currently dominates the market. However, the segment due to its relatively lower efficacy, patent loss and growing competition from Linaclotide will lose its dominance in the upcoming future. The Linaclotide drugs market for CIC treatment is anticipated to grow at a CAGR of 7.7% during 2017 - 2025.

Analyzing the symptoms, constipation is not considered as a disease but a condition, side effect or syndrome. This factor greatly contributes to the lesser visits from patients to address the issue. Thus over 65% of the CIC drugs market is captured by OTC drugs segment. The OTC market is expected to continue to dominate the market at a CAGR of 6.6% during 2017 - 2025.

The CIC drugs market is currently open for further research and development and thus introduction of novel pharmaceutical solutions. Actavis, Chugai Pharmaceutical, Ferrin International, Synergy Pharmaceuticals and others are among the top payers active in the global chronic idiopathic constipation drugs market.

Key Topics Covered:

Chapter 1 Preface

Chapter 2 Executive Summary

Chapter 3 Global CIC Drugs Market Analysis

Chapter 4 Global CIC Drugs Market, by Drug Type

Chapter 5 Global CIC Drugs Market, by Prescription Type

Chapter 6 Global CIC Drugs Market, by Geography

Chapter 7 Company Profiles

  • Actavis
  • Chugai Pharmaceutical
  • Ferring International Center S.A.
  • Synergy Pharmaceuticals
  • Pfizer
  • GlaxoSmithKline
  • Roche Holding AG
  • Sanofi
  • Bayer AG
  • Salix Pharmaceuticals Ltd
  • Sucampo Pharmaceuticals Inc
  • Ironwood Pharmaceuticals inc
  • Progenics pharmaceuticals inc

For more information about this report visit

Media Contact:

Laura Wood, Senior Manager  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


View original content:

©2017 PR Newswire. All Rights Reserved.

Powered by Frankly
3514 State St. Erie, PA 16508
Newsroom: (814) 454-8812
Business offices: (814) 454-5201
Share Stories
Submit your stories to our site!
Share Photos
Share your photos in our community galleries
RSS Feeds
All content © Copyright 2000 - 2017 WICU. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.
                   WICU/WSEE - 3514 State Street Erie, PA 16508 - (814) 454-5201 -